Aziyo Biologics receives $25 million loan facility from SWK Holdings

Chicago, Aug. 10 – Aziyo Biologics, Inc. announced a new $25 million loan facility with SWK Holdings, according to a press release.

The facility provides for an initial term loan of $21 million with an optional $4 million draw, subject to the achievement of specified operational and financial metrics by Sept. 30, 2023.

The loan facility also allows for the establishment of a new asset-based revolver of up to $8 million.

Proceeds from the initial term loan will be used to fund the ongoing commercial and product development initiatives, refinance existing debt and to pay off all such other outstanding debt.

SWK specializes on global health care lending.

Aziyo Bioligics is a commercial-stage regenerative medicine company focused on better outcomes for patients receiving implantable medical devices. The company is based in Silver Spring, Md.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.